Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
- DOI
- 10.1111/irv.70027
- Published
- 2024 Nov
- Container
- Influenza and other respiratory viruses
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/irv.70027,
title = {Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.},
author = {DeCuir J and Surie D and Zhu Y and Lauring AS and Gaglani M and McNeal T and Ghamande S and Peltan ID and Brown SM and Ginde AA and Steinwand A and Mohr NM and Gibbs KW and Hager DN and Ali H and Frosch A and Gong MN and Mohamed A and Johnson NJ and Srinivasan V and Steingrub JS and Khan A and Busse LW and Duggal A and Wilson JG and Qadir N and Chang SY and Mallow C and Kwon JH and Exline MC and Shapiro NI and Columbus C and Vaughn IA and Ramesh M and Safdar B and Mosier JM and Casey JD and Talbot HK and Rice TW and Halasa N and Chappell JD and Grijalva CG and Baughman A and Womack KN and Rhoads JP and Swan SA and Johnson C and Lewis N and Ellington S and Dawood FS and McMorrow M and Self WH and Investigating Respiratory Viruses in the Acutely Ill (IVY) Network},
year = {2024},
journal = {Influenza and other respiratory viruses},
doi = {10.1111/irv.70027},
url = {https://doi.org/10.1111/irv.70027}
}RIS
TY - JOUR TI - Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023. AU - DeCuir J AU - Surie D AU - Zhu Y AU - Lauring AS AU - Gaglani M AU - McNeal T AU - Ghamande S AU - Peltan ID AU - Brown SM AU - Ginde AA AU - Steinwand A AU - Mohr NM AU - Gibbs KW AU - Hager DN AU - Ali H AU - Frosch A AU - Gong MN AU - Mohamed A AU - Johnson NJ AU - Srinivasan V AU - Steingrub JS AU - Khan A AU - Busse LW AU - Duggal A AU - Wilson JG AU - Qadir N AU - Chang SY AU - Mallow C AU - Kwon JH AU - Exline MC AU - Shapiro NI AU - Columbus C AU - Vaughn IA AU - Ramesh M AU - Safdar B AU - Mosier JM AU - Casey JD AU - Talbot HK AU - Rice TW AU - Halasa N AU - Chappell JD AU - Grijalva CG AU - Baughman A AU - Womack KN AU - Rhoads JP AU - Swan SA AU - Johnson C AU - Lewis N AU - Ellington S AU - Dawood FS AU - McMorrow M AU - Self WH AU - Investigating Respiratory Viruses in the Acutely Ill (IVY) Network PY - 2024 JO - Influenza and other respiratory viruses DO - 10.1111/irv.70027 UR - https://doi.org/10.1111/irv.70027 ER -
APA
J, D., D, S., Y, Z., AS, L., M, G., T, M., S, G., ID, P., SM, B., AA, G., A, S., NM, M., KW, G., DN, H., H, A., A, F., MN, G., A, M., NJ, J., V, S., JS, S., A, K., LW, B., A, D., JG, W., N, Q., SY, C., C, M., JH, K., MC, E., NI, S., C, C., IA, V., M, R., B, S., JM, M., JD, C., HK, T., TW, R., N, H., JD, C., CG, G., A, B., KN, W., JP, R., SA, S., C, J., N, L., S, E., FS, D., M, M., WH, S., & Network, I. R. V. I. T. A. I. (. (2024). Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.. Influenza and other respiratory viruses. https://doi.org/10.1111/irv.70027
Source records
- pubmed · retrieved 2026-09-26T11:14:27.457Z